Research and Practice in Thrombosis and Haemostasis · 2024 · 10 citations · 54 references
MedicineOncologyPharmacotherapyCancer PreventionHemostasisRisk AssessmentAnticoagulant TherapyThromboembolic DiseaseThromboembolism PreventionThrombosisThrombosis PreventionVenous ThromboembolismCancer-associated Thrombosis PreventionHealth Risk Assessment ModelsLow-molecular-weight Heparin TherapyRisk Assessment ModelsState-of-the-art ReviewThromboprophylaxis In Cancer PatientsThromboprophylaxis In Medical InpatientsVenous Thromboembolism Assessment
Venous thromboembolism remains a major cause of morbidity and mortality among ambulatory cancer patients, necessitating effective risk assessment and prevention strategies. Despite the availability of risk assessment models and guidelines recommending primary thromboprophylaxis with low-molecular-weight heparins or direct oral anticoagulants, the application of these strategies is inconsistent. This review provides an overview of the current state-of-the-art venous thromboembolism risk assessment and thromboprophylaxis in ambulatory patients with cancer, focusing on existing risk assessment models and the latest guideline recommendations. Finally, it summarizes gaps in knowledge, discusses future directions, and highlights recent advances and state-of-the-art research presented at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand.
54
Extracellular DNA traps promote thrombosis
Tobias A. Fuchs, Alexander Brill, Daniel Duerschmied et al. · Proceedings of the National Academy of Sciences · 2010 · 2.4K citations · Full text
Medicine, Immunology, Pathobiology +17
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana, Nicole M. Kuderer, Eva Culakova et al. · Blood · 2008 · 2.2K citations · Full text
Medicine, Hematology, Oncology +14
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick et al. · New England Journal of Medicine · 2018 · 847 citations · Full text
Medicine, Oncology, Pharmacotherapy +17